Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Kawasaki disease
1. Dr. Sachin Soni
DNB Pediatrics
Indraprastha Apollo Hospital,
New Delhi
www.dnbpediatrics.com
2. What is it?
Medium vessel vasculitis presents as acute febrile
illness of childhood, characterized by coronary
arteries anomaly in 15-25% of affected
individuals
www.dnbpediatrics.com
3. Epidemiology
Its common pediatric disorder with the annual incidence
range 60-150 per 100,000
Commonest pediatric vasculitis in children below 5
years of age(1-3)
Commonest vasculitic disorder amongst all ages
www.dnbpediatrics.com
5. Pathogenesis
Acute or subacute stages: Inflammatory infiltration of vascular wall, initially
polymorphonuclear cells thereafter by macrophages, lymphocytes
(primarily CD8+ T cells), and plasma cells
Eedema of endothelial and smooth muscle cells
IgA plasma cells are prominent in the inflammatory infiltrate
In most severely affected vessels, inflammation involves all three layers of the vascular wall
Destruction of the internal elastic lamina
Loss of structural integrity weakens the vessel wall
Dilation (ectasia) saccular or fusiform aneurysm formation
Thrombi in lumen and obstruct blood flow
vascular wall can become progressively fibrotic, marked intimal proliferation
Arterial stenosis or occlusion
www.dnbpediatrics.com
6. EPIDEMIOLOGIC CASE DEFINITION
(CLASSIC CLINICAL CRITERIA)
Fever persisting for at least 5 days
Presence of at least 4 principle feature
1- Changes in extremities:A- Acute:- Erythema of palm, soles and edema of hand and feet
B- Sub acute:- Periungul peeling of finger, toes in 2-3
polymorphus exanthema
2- B/L Bulbar conjunctival injection without exudates
3- Changes in lip and oral cavity:- Erythema, lip
cracking, strawberry tongue, diffuse injection of oral and
pharyngeal mucosa
4- Cervical lymphadenopathy (>1.5 cm diameter), usually
unilateral
www.dnbpediatrics.com
7. Other Clinical Findings
Cardiovascular findings
Congestive heart failure, myocarditis,
pericarditis, valvular regurgitation,
Coronary artery abnormalities, Aneurysms
of medium-sized noncoronary arteries
Raynaud phenomenon, Peripheral
gangrene
Musculoskeletal system
Arthritis, arthralgias
Gastrointestinal tract
Diarrhea, vomiting, abdominal pain, Hepatic
dysfunction, Hydrops of gallbladder
Central nervous system
Extreme irritability, Sensoryneural hearing
loss, Aseptic meningitis,
Genitourinary system
Urethritis/meatitis
www.dnbpediatrics.com
15. Coronary Artery Aneurysm
Coronary angiogram demonstrating giant aneurysm of the left anterior
descending coronary artery (LAD) with obstruction and giant aneurysm of
the right coronary artery (RCA) with an area of severe narrowing in 6 yr old
boy
www.dnbpediatrics.com
16. Two-dimensional echocardiography
Most useful test to monitor development of coronary
artery abnormalities
Brightness of the arterial walls and lack of normal
tapering of the vessels
Coronary artery dimensions, adjusted for body surface
area (BSA), are significantly increased in the first 5 wk
after presentation
BSA-adjusted coronary artery dimensions on baseline
echocardiography in the first 10 days of illness to be
good predictors of CAD
www.dnbpediatrics.com
17. Aneurysm defined by Japanese Ministry of Health
classified as: Small (<5 mm internal diameter)
Medium (5-8 mm internal diameter)
Giant (>8 mm internal diameter)
Echocardiography performed at diagnosis and after 2-3 wk
of illness
If the results are normal, repeat study should be performed
6-8 wk after onset of illness
www.dnbpediatrics.com
18. Diagnosis
Classic KD:- Diagnostic criteria
Fever for at least 4 days and at least four of five of
above principal characteristics of the illness
Atypical or incomplete KD:
Patients have persistent fever but fewer than four of
the five characteristics
In these patients, laboratory and echocardiographic
data can assist in the diagnosis
Incomplete cases are most frequent in infants,
who, unfortunately, also have the highest likelihood
of development of coronary artery abnormalities
www.dnbpediatrics.com
23. LONG-TERM THERAPY FOR PATIENTS WITH
CORONARY ABNORMALITIES
Aspirin 3-5 mg/kg once daily orally
Clopidogrel 1 mg/kg/day (max 75 mg/day)
Most experts add warfarin or low-molecular-weight
heparin for those patients at particularly high risk of
thrombosis
www.dnbpediatrics.com
24. ACUTE CORONARY THROMBOSIS
Fibrinolytic therapy with tissue plasminogen activator
Or
Other thrombolytic agent under supervision of a
pediatric cardiologist
www.dnbpediatrics.com
26. • Defined by persistent or recrudescent fever 36 hr
after completion of the initial IVIG infusion
• Another dose of IVIG at 2 g/kg is administered to
patients with IVIG resistance.
• Intravenous methylprednisolone
• If a second dose of IVIG or corticosteroids are
ineffective
• Cyclophosphamide and plasmapheresis.
• Tumor necrosis factor inhibitor infliximab
www.dnbpediatrics.com